News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Panel To Vet Boehringer Ingelheim Corporation Blood Thinner September 20



8/26/2010 10:06:55 AM

FRANKFURT, Aug 26 (Reuters) - A committee advising the U.S. Food and Drug Administration (FDA) will discuss Boehringer Ingelheim's Pradaxa pill on Sept. 20, raising the prospect of a speedy market entry for the first drug in a new class of blood thinners.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES